US 8168604
Antisense antiviral compounds and methods for treating a filovirus infection
granted A61PA61P31/14
Quick answer
US patent 8168604 (Antisense antiviral compounds and methods for treating a filovirus infection) held by The United States of America as represented by the Army Medical Research and Material Command expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Army Medical Research and Material Command
- Grant date
- Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P31/14